Dr. Reddy’s announced the launch of Desloratadine Orally Disintegrating Tablets (ODT), the generic version of Merck‘s Clarinex Reditabs. Clarinex is an antihistamine indicated for the treatment of seasonal allergic rhinitis (for patients ≥2 years old), perennial allergic rhinitis, and chronic idiopathic urticaria (for patients ≥6 months old).

Desloratadine is a long-acting tricyclic histamine antagonist with selective H1-activity. Desloratadine is presumed to inhibit histamine release from human mast cells.

Desloratadine ODT is available in 2.5mg and 5mg strengths in 30-count unit dose packages.

For more information call (908) 203-4933 or visit www.drreddys.com